CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Stanford Medicine · Stanford University · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,735
total citations
- FWCI
- 19.05
- Percentile
- 100%
- References
- 48
Citations per year
Authors
8Topics & keywords
Topics
Keywords
- Biology
- Myeloid leukemia
- Stem cell
- Antibody
- CD47
- Myeloid cells
- Cancer research
- Leukemia
No related works found for this paper.